All News #Library
Biotech
Eradivir Announces Nomination of Its Development Candidate EV148
12 Feb 2026 //
BUSINESSWIRE
Eradivir`s EV25 Excels Result In Phase 2a Influenza Trial
15 Oct 2025 //
PHARMIWEB
Eradivir Secures $10 Million In Private Financing
07 Oct 2025 //
PHARMIWEB
Eradivir to Present at 2025 BIO International Convention
10 Jun 2025 //
BUSINESSWIRE

Market Place
Sourcing Support